Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage

By Pietropolli A.   Giuliani E.   Bruno V.   Patrizi L.   Piccione E.   Ticconi C.  

Journal of Obstetrics & Gynaecology, Vol. 34, Iss. 3, 2014-04 ,pp. : 229-234

Informa Healthcare

Access to resources Recommend Favorite

Plasminogen activator/plasminogen activator inhibitor-1 and cytokine modulation by the PROACT&unknown; system

By Ivarsson M.-L.   Diamond M.P.   Falk P.   Holmdahl L.  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 987-992

Elsevier

Access to resources Recommend Favorite

Low-dose oral combination of 17β-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1

By Borgfeldt C.   Li C.   Samsioe G.  

Climacteric, Vol. 7, Iss. 1, 2004-01 ,pp. : 78-85

Informa Healthcare

Access to resources Recommend Favorite

Use of angiotensin-converting enzyme inhibitors in patients with diabetic nephropathy

By How H. Y.   Sibai B. M.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 12, Iss. 6, 2002-12 ,pp. : 402-407

Informa Healthcare

Access to resources Recommend Favorite

Polymorphisms in the vascular endothelial growth factor gene associated with recurrent spontaneous miscarriage

By li Luo   donghong Li   shuguang Wei   hongbo Zhang   jing Zhao   shengbin Li  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Iss. 7, 2013-05 ,pp. : 686-690

Informa Healthcare

Access to resources Recommend Favorite